Tubular Injury in a Rat Model of Type 2 Diabetes Is Prevented by Metformin
Open Access
- 21 February 2011
- journal article
- Published by American Diabetes Association in Diabetes
- Vol. 60 (3), 981-992
- https://doi.org/10.2337/db10-0655
Abstract
OBJECTIVE Chronic hypoxia has been recognized as a key regulator in renal tubulointerstitial fibrosis, as seen in diabetic nephropathy, which is associated with the activation of hypoxia-inducible factor (HIF)-1α. We assess here the effects of the biguanide, metformin, on the expression of HIF-1α in diabetic nephropathy using renal proximal tubular cells and type 2 diabetic rats. RESEARCH DESIGN AND METHODS We explored the effects of metformin on the expression of HIF-1α using human renal proximal tubular epithelial cells (HRPTECs). Male Zucker diabetic fatty (ZDF; Gmi-fa/fa) rats were treated from 9 to 39 weeks with metformin (250 mg ⋅ kg−1 ⋅ day−1) or insulin. RESULTS Metformin inhibited hypoxia-induced HIF-1α accumulation and the expression of HIF-1–targeted genes in HRPTECs. Although metformin activated the downstream pathways of AMP-activated protein kinase (AMPK), neither the AMPK activator, AICAR, nor the mTOR inhibitor, rapamycin, suppressed hypoxia-induced HIF-1α expression. In addition, knockdown of AMPK-α did not abolish the inhibitory effects of metformin on HIF-1α expression. The proteasome inhibitor, MG-132, completely eradicated the suppression of hypoxia-induced HIF-1α accumulation by metformin. The inhibitors of mitochondrial respiration similarly suppressed hypoxia-induced HIF-1α expression. Metformin significantly decreased ATP production and oxygen consumption rates, which subsequently led to increased cellular oxygen tension. Finally, metformin, but not insulin, attenuated tubular HIF-1α expression and pimonidazole staining and ameliorated tubular injury in ZDF rats. CONCLUSIONS Our data suggest that hypoxia-induced HIF-1α accumulation in diabetic nephropathy could be suppressed by the antidiabetes drug, metformin, through the repression of oxygen consumption.Keywords
This publication has 51 references indexed in Scilit:
- Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy stateJCI Insight, 2010
- Review: Metformin: Potential benefits and use in chronic kidney diseaseNephrology, 2010
- Novel Assay of Metformin Levels in Patients With Type 2 Diabetes and Varying Levels of Renal FunctionDiabetes Care, 2010
- mTOR and HIF-1α-mediated tumor metabolism in an LKB1 mouse model of Peutz-Jeghers syndromeProceedings of the National Academy of Sciences of the United States of America, 2009
- Adaptation to hypoxia in the diabetic rat kidneyKidney International, 2008
- Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transitionJCI Insight, 2007
- AMPK activation inhibits the expression of HIF-1α induced by insulin and IGF-1Biochemical and Biophysical Research Communications, 2006
- Hypoxia-induced apoptosis in cultured glomerular endothelial cells: Involvement of mitochondrial pathwaysKidney International, 2003
- New targets of AMP-activated protein kinaseBiochemical Society Transactions, 2003
- Role of AMP-activated protein kinase in mechanism of metformin actionJCI Insight, 2001